Elias Mossialos
Elias Mossialos is Brian Abel-Smith Professor of Health Policy and Director of LSE Health. He was the founding Head of the LSE Department of Health Policy (2017-2020). In 1998, Professor Mossialos co-founded the European Observatory on Health Systems and Policies, a major health policy research and knowledge transfer programme.
His research focuses on transformation strategies for health organisations, healthcare regulation, access to healthcare, healthcare quality and patient outcomes, digital health, healthcare financing, pharmaceutical policies, antimicrobial resistance (AMR), and cancer care and policy.
In 2010 he was awarded the Andrija Stampar medal by the Association of Schools of Public Health in Europe (ASPHER) for contributions to European public health. He received the 2021 Choice award by the Association of US College and Research Libraries for Outstanding Academic Title, the 2002 and 2007 Baxter Awards from the European Health Management Association for the best publication in health policy and management in Europe, the 2022 Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. In 2009, under his directorship, LSE Health was honoured with the biennial Queen's Anniversary Prize for Higher and Further Education in the UK.
He has been profiled in both the Lancet and BMJ, and co-chaired the LSE-Lancet Commission on the future of the UK NHS and the WHO Review Panel of the Overall programme review of the global strategy and plan of action on public health, innovation and intellectual property.
He has direct experience of government, having served in Greece as a Member of Parliament (2009-12), and as Minister of State and chaired the Parliament's Special Permanent Committee on Monitoring the Social Security System.
Professor Mossialos has been an active participant in policy debates, advising the World Health Organization, the European Parliament, the European Commission, the World Bank, Ministries of Health in Austria, Belgium, Brazil, China, Finland, Greece, Ireland, Kazakhstan, Kuwait, The Netherlands, Russia, Singapore, Slovenia, South Africa, Spain and Sweden and health insurance funds in Croatia, France, Hungary and South Korea. He was a member of the management board of the European Medicines Agency (2000-2003) and served as a senior adviser during the Belgian Presidency of the EU Council in both 2001 and 2010. He also contributed his expertise during the Swedish Presidencies in 2009 and 2023, as well as the Dutch Presidency in 2016, with a particular emphasis on addressing Antimicrobial Resistance.
His research focuses on transformation strategies for health organisations, healthcare regulation, access to healthcare, healthcare quality and patient outcomes, digital health, healthcare financing, pharmaceutical policies, antimicrobial resistance (AMR), and cancer care and policy.
In 2010 he was awarded the Andrija Stampar medal by the Association of Schools of Public Health in Europe (ASPHER) for contributions to European public health. He received the 2021 Choice award by the Association of US College and Research Libraries for Outstanding Academic Title, the 2002 and 2007 Baxter Awards from the European Health Management Association for the best publication in health policy and management in Europe, the 2022 Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. In 2009, under his directorship, LSE Health was honoured with the biennial Queen's Anniversary Prize for Higher and Further Education in the UK.
He has been profiled in both the Lancet and BMJ, and co-chaired the LSE-Lancet Commission on the future of the UK NHS and the WHO Review Panel of the Overall programme review of the global strategy and plan of action on public health, innovation and intellectual property.
He has direct experience of government, having served in Greece as a Member of Parliament (2009-12), and as Minister of State and chaired the Parliament's Special Permanent Committee on Monitoring the Social Security System.
Professor Mossialos has been an active participant in policy debates, advising the World Health Organization, the European Parliament, the European Commission, the World Bank, Ministries of Health in Austria, Belgium, Brazil, China, Finland, Greece, Ireland, Kazakhstan, Kuwait, The Netherlands, Russia, Singapore, Slovenia, South Africa, Spain and Sweden and health insurance funds in Croatia, France, Hungary and South Korea. He was a member of the management board of the European Medicines Agency (2000-2003) and served as a senior adviser during the Belgian Presidency of the EU Council in both 2001 and 2010. He also contributed his expertise during the Swedish Presidencies in 2009 and 2023, as well as the Dutch Presidency in 2016, with a particular emphasis on addressing Antimicrobial Resistance.
less
InterestsView All (7)
Uploads